Target intelligence / Profile preview

Mohawk homeobox (MKX) (MKX)

Target
MKX
Molecular classification
Transcription factor, Homeobox protein, TALE family homeobox protein
01

Overview

Mohawk homeobox (MKX) is a member of the Three Amino acid Loop Extension (TALE) family of homeobox transcription factors, primarily recognized for its pivotal role in the development and homeostasis of tendons and ligaments (UniProt Q86WJ1). It is expressed in the progenitor cells of the musculoskeletal system, where it regulates the transcription of essential extracellular matrix components, including type I collagen and tenomodulin (Ito et al., 2010, Nature Communications). Research indicates that MKX is necessary for the proper alignment and maturation of collagen fibers, and its deficiency leads to hypoplastic tendons and increased susceptibility to injury (Liu et al., 2015, PNAS). In the context of disease, MKX downregulation is linked to tendinopathy and intervertebral disc degeneration, making it a significant target for regenerative medicine (Nakamichi et al., 2016, Nature Communications). Current therapeutic explorations involve using MKX-based gene therapy or mRNA delivery to stimulate tissue repair and restore mechanical properties in damaged musculoskeletal tissues (Nakamichi et al., 2018, Science Signaling).

Other names
Mohawk homeobox proteinC10orf48IR10Homeobox protein Mohawk
02

Mechanism of action

MKX acts as a transcriptional activator that binds to specific DNA sequences (e.g., TGACAG) to promote the expression of tenogenic genes such as Type I Collagen (COL1A1), Scleraxis (SCX), and Tenomodulin (TNMD), thereby driving the differentiation of mesenchymal stem cells into tenocytes and maintaining tendon homeostasis (PubMed: 20461080).

03

Biological functions

Tendon developmentLigament developmentTranscriptional regulationChondrogenesisExtracellular matrix organizationSkeletal muscle development
04

Disease associations

TendinopathyIntervertebral disc degenerationLigament injuryMusculoskeletal disorders
05

Safety considerations

Ectopic ossificationOff-target gene expression in non-musculoskeletal tissuesPotential for tissue fibrosisImmunogenicity associated with viral vector delivery in gene therapy
06

Biomarkers

MKX mRNA expressionTenomodulin (TNMD)Scleraxis (SCX)Type I Collagen (COL1A1)

Beyond the preview

Go deeper on Mohawk homeobox (MKX) (MKX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mohawk homeobox (MKX) (MKX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call